Azithromycin

Antibiotic with anti-inflammatory properties

Phase of research

FDA-approved for Cystic Fibrosis

How it helps

Anti-Infective

General information

Azithromycin is a broad-spectrum antibiotic. It is sold under the name e.g., Zithromax® and was approved in the USA in 1996. It is used to treat respiratory, enteric and genitourinary infections. In relation to cystic fibrosis, our AIM tool found the data that azithromycin can reduce the risk of pulmonary exacerbation and improve clinically relevant endpoints in patients chronically infected with Pseudomonas aeruginosa.  

Azithromycin on PubChem
Azithromycin on DrugBank
Azithromycin on Wikipedia

Synonyms

N/A

Marketed as

Dietary sources

N/A

Structure image not available

C38H72N2O12

Drug-Mutation Relation

Treats

Mutation Number of sources Average impact factor
General effect
4 18.51
Link Tested on Impact factor Notes
Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. humans 16.49
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. humans 30.01
Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. humans 21.46
Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. humans 6.06

Does not treat

Mutation Number of sources Average impact factor